Longboard Pharmaceuticals
Yahoo Finance • 10 months ago
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher
You've no doubt heard a lot about the "Magnificent Seven" stocks. Each stock in this group -- Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta Platforms, and Tesla -- delivered gains of 48% or more in 2023. Nvidia more than tripled, while... Full story
Yahoo Finance • 2 years ago
Longboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
LA JOLLA, Calif., April 11, 2023--(BUSINESS WIRE)--Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced... Full story
Yahoo Finance • 2 years ago
Longboard Pharmaceuticals to Participate in Five Upcoming Epilepsy-Focused Conferences this Summer
SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that... Full story
Yahoo Finance • 3 years ago
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
Longboard Pharmaceuticals, Inc. Phase 1 data for LP352, a potential treatment for seizures associated with a broad range of severe epilepsies, presented at the American Academy of Neurology (AAN) Annual Meeting Initiated Phase 1b/2a PACI... Full story
Yahoo Finance • 3 years ago
Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting
Two poster presentations highlight Phase 1 data for LP352 in healthy volunteers SAN DIEGO, April 01, 2022 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developi... Full story
